The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ReNeuron Annual Loss Narrows On Finance Income And Licence Fee

Thu, 11th Jul 2019 11:36

(Alliance News) - ReNeuron Group PLC on Thursday said its loss narrowed in its most recent financial year after it received an exclusivity fee and increased finance income.

Shares in ReNeuron were down 11% at 244.40 pence in late morning trade.

In its financial year to March 31, the cell-based therapeutics company posted a GBP17.2 million pretax loss, narrowed from GBP21.0 million the year before.

This reduction in loss was the result of a GBP1.9 million exclusivity fee received from out-licencing negotiations, with no such fee received the year before.

Adding to this, finance income increased to GBP1.1 million from GBP320,000 and the company incurred no finance expense compared to GBP911,000 of finance expense the year prior.

Revenue from royalty income was GBP49,000, up from GBP43,000.

Looking ahead, ReNeuron said it is awaiting results from trials of its CTX cell therapy candidate in chronic stroke disability, as well as trials of its hRPC candidate in the blindness-causing disease retinitis pigmentosa.

The company has signed an exclusive licence with Fosun Pharma in China for its CTX and hRPC programmes.

"We are pleased to be working with Fosun Pharma as our partner for China, following the signing of the exclusive licence agreement for both our CTX and hRPC programmes in that territory. We are also encouraged by the level of interest other potential collaborators are showing in all of our programmes, including our exosome technology which is being developed as a novel system for delivering third party drugs," said ReNeuron.

More News
1 Jul 2021 17:05

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

Read more
9 Jun 2021 17:47

TRADING UPDATES: Ted Baker results in line; Gulf Marine raises cash

TRADING UPDATES: Ted Baker results in line; Gulf Marine raises cash

Read more
20 May 2021 20:23

TRADING UPDATES: Amigo wants suspension lift; Young's sinks to loss

TRADING UPDATES: Amigo wants suspension lift; Young's sinks to loss

Read more
19 Mar 2021 16:43

ReNeuron signs new collaboration agreements

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced the signing of new collaboration agreements with a major pharmaceutical company and leading academic institutions in the UK and mainland Europe on Friday.

Read more
19 Mar 2021 11:34

ReNeuron inks commercial collaboration deals for exosome platform

ReNeuron inks commercial collaboration deals for exosome platform

Read more
19 Mar 2021 11:20

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

Read more
12 Mar 2021 15:39

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

Read more
27 Jan 2021 13:43

IN BRIEF: Schroder UK Public Private Sells Basket Of Seven Assets

IN BRIEF: Schroder UK Public Private Sells Basket Of Seven Assets

Read more
15 Jan 2021 15:29

IN BRIEF: ReNeuron Treats First Patient In Extended Retinal Study

IN BRIEF: ReNeuron Treats First Patient In Extended Retinal Study

Read more
17 Dec 2020 22:00

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

Read more
11 Dec 2020 14:26

ReNeuron Conditionally Raises GBP17.5 Million Through Placing

ReNeuron Conditionally Raises GBP17.5 Million Through Placing

Read more
24 Nov 2020 14:41

IN BRIEF: ReNeuron Interim Loss Widens; Raises GBP15 Million

IN BRIEF: ReNeuron Interim Loss Widens; Raises GBP15 Million

Read more
23 Nov 2020 19:09

UK TRADING UPDATE SUMMARY: ReNeuron Plans Fundraise To Support Study

UK TRADING UPDATE SUMMARY: ReNeuron Plans Fundraise To Support Study

Read more
10 Sep 2020 16:01

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

Read more
3 Sep 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.